References
- Burman K. D., Strum D., Diamond R. C., Djuh Y.-Y., Wright F. D., Earll J. M., Wartofsky L. A radioimniunoassay for 3,3′-L-diiodothyronine (3,3′-T2). J. clin. Endocr 1977; 45: 339
- Cavalieri R. R., Sung L. C., Becker C. E. Effects of phenobarbital on thyroxine and triiodothyronine kinetics in Graves' disease. J. clin. Enrlocr 1973; 37: 308
- Chin W., Schussler G. C. Decreased serum free thyroxine concentration in patients treated with diphenylhydantoin. J. clin. Endocr 1968; 28: 28
- Chopra I. J. An assessment of daily production and significance of thyroidal secretion of 3,3′,5′-tri-iodothyronine (reverse T,) in man. J. clin. Invest 1976; 58: 58
- Cullen M. J., Burger A. G., Ingbar S. H. Effects of diphenylhydantoin on peripheral thyroid hormone economy and the conversion of T4 to T3. Israel J. med. Sci 1973; 8: 1868
- Eichelbaum Bertilsson M. L., Rane A., Sjöqvist F. Auto induction of carbamazepine metabolism in man. Anticonvulsant Drugs and Enzyme-induction, A. Richers, F. R. Woodford. Elsevier, Amsterdam 19763; 147
- Fichsel H., Knöpfle G. Influence of anticon-vulsive drugs on thyroid hormones in epileptic children. Adconces in Epileptology, H. Meinardi, A. J. Rowan. Swets & Zeitlinger B.V., Amsterdam 19783; 346
- Gallagher B. B., Baumel I. P. Primidone. Bio-transformation. Antirpileptic Drugs, D. M. Woodbury, J. K. Perry, R. P. Schmidt. Raven Press, New York 19723; 361
- Gavin L. A., Hammond M. E., Castle J. N., Cavalieri R. R. 3,3′-diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. J. clin. Invest 1979; 63: 1276
- Gerber N., Arnold K. Studies on the metabolism of diphenylhydantoin in mice. J. Pharmac. exp. Ther 1969; 167: 167
- Hansen J. M., Skovsted L., Lauridsen L., Kirke-Gaard C., Siersbaek-Nielsen K. The effect of diphenylhydantoin on thyroid function. J. clin. Enclocr 1974; 39: 785
- Helenius T., Liewendahl K. Abnormal thyroid function tests in severe non-thyroidal illness: diagnostic and pathophysiologic aspects. Scand. J. elin. Lab. Invest 1979; 39: 389
- Heyma P., Larkins R. G., Perry-Keene D., Peter C. T., Ross D., Sloman J. G. Thyroid hormone levels and protein binding in patients on long-term diphenylhydantoin treatment. Clin. Enrlocr 1977; 6: 369
- Hufner M., Knöpfle M. Pharmacological influences on T4 to T3 conversion in rat liver. Clinica chim. Acta 1976; 72: 337
- Hvidberg E. F., Dam M. Clinical pharnia-cokinetics of anticonvulsants. Clin. Pharmacokinet 1976; 1: 161
- Larsen P. R., Atkinson A. J., Jr., Wellman H. N., Goldsmith R. E. The effect of diphenylhydantoin on thyroxine metabolism in man. J. clin. Invest 1970; 49: 1266
- Leichter S. B., Kirstein L., Martin N. D. Thyroid function and growth hormone secretion in ami-triptyline-treated depression. Am. J. Psych 1977; 134: 1270
- Liewendahl K., Helenius T. Comparison of free thyroxine indices and 'corrected' thyroxine tests. Clinica chim. Acta 1975; 64: 263
- Liewendahl K., Majuri H. Thyroxine, triiodothyronine, and thyrotropin in serum during long-term diphenylhydantoin therapy. Scand. J. clin. Lab. Invest 1976; 36: 141
- Liewendahl K., Majuri H., Helenius T. Thyroid function tests in patients on long-term treatment with various anticonvulsant drugs. Clin. Enclocr 1978; 8: 185
- Mendoza D. M., Flock E. V., Owen C. A., Jr., Paris J. Effect of 5,5′-diphenylhydantoin on the metabolism of L-thyroxine-131I in the rat. Endocrinology 1966; 79: 106
- Oppenheimer J. H., Bernstein G., Surks M. I. Increased thyroxine turnover and thyroidal function after stimulation of hepato cellular binding of thyroxine by phenobarbital. J. clin. Invest. 1968; 47: 47
- Remmer H. Amount of activity of microsomal drug-oxidase in the liver. Anticonvulsant Drugs and Enzyme-induction, A. Richers, F. R. Woodford. Elsevier, Amsterdam 19763; 108
- Rootwelt K., Ganes T., Johannessen T. Effect of carbamazepine, phenytoin and phenobarbitone on serum levels of thyroid hormones and thyrotropin in humans. Scand. J. clin. Lab. Invest 1978; 38: 731
- Stjernholm M. R., Alsever R. N., Rudolph M. C. Thyroid-function tests in diphenylhydantoin-treated patients. Clin. Chem 1975; 21: 1388
- Yeo P. P.B., Bates D., Howe J. G., Ratcliffe W. A., Schardt C. W., Heath A., Evered D. C. Anticonvulsants and thyroid function. Br. med J 1978; 1: 1581